HK1016886A1 - Drug delivery system for two or more active substances - Google Patents

Drug delivery system for two or more active substances

Info

Publication number
HK1016886A1
HK1016886A1 HK99101986A HK99101986A HK1016886A1 HK 1016886 A1 HK1016886 A1 HK 1016886A1 HK 99101986 A HK99101986 A HK 99101986A HK 99101986 A HK99101986 A HK 99101986A HK 1016886 A1 HK1016886 A1 HK 1016886A1
Authority
HK
Hong Kong
Prior art keywords
delivery system
drug delivery
active substances
substances
active
Prior art date
Application number
HK99101986A
Other languages
English (en)
Inventor
R J J Groenewegen
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8228203&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1016886(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of HK1016886A1 publication Critical patent/HK1016886A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK99101986A 1997-04-11 1999-05-04 Drug delivery system for two or more active substances HK1016886A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97201098 1997-04-11

Publications (1)

Publication Number Publication Date
HK1016886A1 true HK1016886A1 (en) 1999-11-12

Family

ID=8228203

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99101986A HK1016886A1 (en) 1997-04-11 1999-05-04 Drug delivery system for two or more active substances

Country Status (27)

Country Link
US (1) US5989581A (hu)
EP (1) EP0876815B1 (hu)
JP (2) JP4982670B2 (hu)
KR (1) KR100492676B1 (hu)
CN (1) CN1163222C (hu)
AR (1) AR011709A1 (hu)
AT (1) ATE211646T1 (hu)
AU (1) AU726934B2 (hu)
BR (1) BR9801027B1 (hu)
CA (1) CA2233753C (hu)
CZ (1) CZ294099B6 (hu)
DE (1) DE69803112T2 (hu)
DK (1) DK0876815T3 (hu)
ES (1) ES2171283T3 (hu)
HK (1) HK1016886A1 (hu)
HU (1) HU222343B1 (hu)
ID (1) ID21259A (hu)
IL (2) IL123813A0 (hu)
NO (1) NO320394B1 (hu)
NZ (1) NZ330145A (hu)
PL (1) PL192449B1 (hu)
PT (1) PT876815E (hu)
RU (1) RU2206325C2 (hu)
SG (1) SG65061A1 (hu)
TR (1) TR199800648A1 (hu)
TW (1) TW358031B (hu)
ZA (1) ZA982911B (hu)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW358031B (en) * 1997-04-11 1999-05-11 Akze Nobel N V Drug delivery system for 2 or more active substances
US6039968A (en) † 1997-06-24 2000-03-21 Hoechst Marion Roussel Intravaginal drug delivery device
US6361780B1 (en) * 1998-11-12 2002-03-26 Cardiac Pacemakers, Inc. Microporous drug delivery system
US6217895B1 (en) 1999-03-22 2001-04-17 Control Delivery Systems Method for treating and/or preventing retinal diseases with sustained release corticosteroids
US6371970B1 (en) 1999-07-30 2002-04-16 Incept Llc Vascular filter having articulation region and methods of use in the ascending aorta
US7369463B1 (en) 2000-02-21 2008-05-06 N.V. Organon Electronic alarm timer for use with a medical regimen
US6375972B1 (en) * 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
US20040115268A1 (en) * 2000-04-26 2004-06-17 Control Delivery Systems, Inc. Systemic delivery of antiviral agents
US7187980B2 (en) * 2001-11-09 2007-03-06 Oscor Inc. Cardiac lead with steroid eluting ring
TWI297685B (en) 2002-04-04 2008-06-11 Organon Nv Non-steroidal progesterone receptor modulators
US8871241B2 (en) * 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
BR0309844A (pt) * 2002-05-07 2005-02-15 Control Delivery Sys Inc Processos para formação de um dispositivo para a distribuição de droga
KR20050072812A (ko) 2002-11-07 2005-07-12 악조 노벨 엔.브이. 안드로겐-수용체와 관련된 질병의 치료에 효과적인 인돌
US7357046B2 (en) * 2002-12-16 2008-04-15 N. V. Organon Method for dissolution testing of a pharmaceutical delivery device
WO2004055209A1 (en) * 2002-12-16 2004-07-01 Akzo Nobel N.V. Vessel, method and apparatus for dissolution testing of an annular pharmaceutical delivery device
EP1620060B1 (en) 2003-04-29 2010-03-24 The General Hospital Corporation Methods and devices for the sustained release of multiple drugs
TWI336627B (en) 2003-05-23 2011-02-01 Organon Nv Drug delivery system,and use and manufacturing method thereof
US7067504B2 (en) * 2004-01-15 2006-06-27 Warner Chilcott Company, Inc. Di-steroidal prodrugs of ethinyl estradiol
JP2007517877A (ja) * 2004-01-15 2007-07-05 ワーナー・チルコット・カンパニー・インコーポレーテッド エストラジオールのジ−ステロイド型プロドラッグ
TWI290837B (en) 2004-03-24 2007-12-11 Organon Nv Drug delivery system
TW200531977A (en) 2004-03-25 2005-10-01 Akzo Nobel Nv Progesterone receptor modulators
TW200602317A (en) 2004-04-23 2006-01-16 Akzo Nobel Nv Novel androgens
EP1814519A1 (en) * 2004-11-16 2007-08-08 Université de Liège Active substance delivery system comprising a hydrogel atrix and microcarriers
CN100366242C (zh) * 2005-01-13 2008-02-06 杭州容立医药科技有限公司 防滑脱阴道药物释放体系及其制造工艺和在制药中的应用
US20100241240A1 (en) * 2005-06-20 2010-09-23 Abbeymoor Medical, Inc. Self-adjusting endourethral device & methods of use
TW200727920A (en) * 2005-06-21 2007-08-01 Organon Nv New regimens for oral monophasic contraceptives
WO2007008474A2 (en) * 2005-07-12 2007-01-18 Warner Chilcott Company, Inc. 3 -ester prodrugs of estradiol
US7795241B2 (en) * 2005-07-12 2010-09-14 Warner Chilcott Company, Llc Derivative prodrugs of ethinyl estradiol
CN1899643B (zh) * 2005-07-20 2010-12-29 上海市计划生育科学研究所 含有抗雌激素和抗孕激素复合制剂的阴道环或宫内释药装置及其制药用途
ES2400091T3 (es) * 2005-08-11 2013-04-05 Massachusetts Institute Of Technology Dispositivo de suministro de fármacos intravesical y método
US20070077269A1 (en) * 2005-10-04 2007-04-05 Woodward John R Method of birth control and hormone regulation
US7989442B2 (en) 2006-09-27 2011-08-02 N.V. Organon Progesterone receptor modulators
WO2008062021A1 (en) * 2006-11-22 2008-05-29 N.V. Organon Vaginal delivery system for mirtazapine
TW200840595A (en) * 2006-12-12 2008-10-16 Organon Nv Oral contraceptive spray
US8063037B2 (en) 2007-05-07 2011-11-22 N. V. Organon Progesterone receptor modulators
US8741329B2 (en) * 2007-09-21 2014-06-03 Merck Sharp & Dohme B.V. Drug delivery system
CA2706384C (en) * 2007-12-11 2016-05-31 Massachusetts Institute Of Technology Implantable drug delivery device and methods for treatment of the bladder and other body vesicles or lumens
BRPI0917135A2 (pt) * 2008-08-09 2015-11-10 Massachusetts Inst Technology dispositivo médico para extensão e retenção em uma vesícula seminal, duto ejaculatório, próstata ou vaso deferente de um paciente, uso de um elastômero reabsorvível, e, dispositivo de bomba osmótica.
US20100040671A1 (en) * 2008-08-12 2010-02-18 Ahmed Salah U Intravaginal Devices With a Rigid Support, Methods of Making, and Uses Thereof
AU2009313304B2 (en) * 2008-11-07 2014-07-24 Vimac Ventures, Llc Devices and methods for treating and/or preventing diseases
FI121000B (fi) * 2008-11-19 2010-06-15 Bayer Schering Pharma Oy Intravaginaalinen antojärjestelmä ja menetelmä sen valmistamiseksi
BRPI1009586A2 (pt) 2009-03-17 2016-03-08 Intervet Int Bv sistema de administração de medicamento zootécnico, e, método para aprimorar o crescimento e ganho de peso em animais de criação
MX2011010607A (es) 2009-04-07 2012-04-02 Catholic Healthcare West Sistema y metodo de estimulacion electrica uterina.
US8568374B2 (en) * 2009-05-04 2013-10-29 Merck Sharp & Dohme B.V. Intrauterine system
KR101429881B1 (ko) 2009-06-03 2014-08-13 포사이트 비젼4, 인크. 전안부 약물 전달
US10543166B2 (en) 2009-06-26 2020-01-28 Taris Biomedical Llc Implantable drug delivery devices and methods of making the same
EP2456421B1 (en) 2009-07-21 2017-04-05 The Population Council, Inc. Multi-layered gradient vaginal ring
US9017312B2 (en) * 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
AU2011238710B2 (en) * 2010-03-28 2015-08-20 Evestra, Inc. Intravaginal drug delivery device
WO2011156674A2 (en) 2010-06-10 2011-12-15 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Thioether prodrug compositions as anti-hiv and anti-retroviral agents
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
EP2632328B1 (en) 2010-10-27 2018-06-13 Dignity Health Uterine electrical stimulation system
US9872983B2 (en) 2010-10-27 2018-01-23 Dignity Health Uterine electrical stimulation system and method
WO2012096985A1 (en) 2011-01-10 2012-07-19 Taris Biomedical, Inc. Lidocaine regimen for the use of sustained treatment of bladder pain and irritative voiding
KR101263916B1 (ko) 2011-01-11 2013-05-13 이장희 성 호르몬 방출 장치 및 이를 이용한 동물 피임 및 발정 유도 방법
JP6043730B2 (ja) * 2011-02-04 2016-12-14 タリス バイオメディカル エルエルシー 低溶解性薬物の制御された放出のための植込み型装置
MX357598B (es) * 2011-07-20 2018-07-16 F Kiser Patrick Dispositivos intravaginales para administración de fármaco.
WO2013029194A1 (es) 2011-08-26 2013-03-07 Universidad De Santiago De Chile Uso de los anti-inflamatorios no esteroidales meloxicam y piroxicam, por via intravaginal, para la interrupción del proceso ovulatorio en la mujer
TR201808748T4 (tr) 2012-09-03 2018-07-23 Ecosea Farming S A Hidrobiyolojik türlerin kültürü ve/veya korunmasına yönelik rezervuar-kafes daldırma sistemi.
SG11201503275RA (en) 2012-11-22 2015-06-29 Bayer Pharma AG Use and application regimen of a pharmaceutical composition containing levonorgestrel and a cox inhibitor for on-demand contraception
FI2964088T3 (fi) 2013-03-08 2023-05-31 Li Galli B V I O Lääkkeiden emätinannostelu- ja/tai diagnostiikkajärjestelmä
CA2903164C (en) 2013-03-15 2024-06-11 Taris Biomedical Llc Drug delivery devices with drug-permeable component and methods
EP3035991B1 (en) 2013-08-19 2020-07-08 TARIS Biomedical LLC Multi-unit drug delivery devices
WO2015035003A1 (en) 2013-09-05 2015-03-12 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Thioether prodrug compositions as anti-hiv and anti-retroviral agents
WO2015055789A1 (en) 2013-10-17 2015-04-23 Bayer Pharma Aktiengesellschaft INTRAVAGINAL USE OF 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, INTRAVAGINAL RINGS COMPRISING 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, AND USE THEREOF IN CONTRACEPTION
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
WO2015086489A1 (en) 2013-12-11 2015-06-18 Merck Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
US10413504B2 (en) * 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
US10918515B2 (en) 2015-03-31 2021-02-16 Merck Sharp & Dohme B.V. Vaginal ring applicator
US20160296532A1 (en) 2015-04-13 2016-10-13 Forsight Vision5, Inc. Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
JP7425534B2 (ja) 2015-04-23 2024-01-31 タリス バイオメディカル エルエルシー 薬物透過性構成要素を有する薬物送達デバイス及び方法
WO2016180764A1 (en) 2015-05-13 2016-11-17 Bayer Oy A long acting drug delivery device and its use in contraception
EP3272333A1 (en) 2016-07-22 2018-01-24 Chemo Research, S.L. Vaginal composition comprising a combination of estrogen and vitamin d
EP3395335A1 (en) 2017-04-24 2018-10-31 Kern Pharma, S.L. Vaginal ring for the simultaneous release of two active ingredients
DE102017113166A1 (de) * 2017-06-14 2018-12-20 Amw Gmbh Depotform zur Abgabe eines Östrogen-Wirkstoffs
US11103460B2 (en) 2017-08-07 2021-08-31 Board Of Regents, The University Of Texas System Fabrication methods for nanodelivery systems for long term controlled delivery of active pharmaceutical ingredients
SG11202005947RA (en) 2018-05-24 2020-07-29 Celanese Eva Performance Polymers Corp Implantable device for sustained release of a macromolecular drug compound
JP2021524840A (ja) 2018-05-24 2021-09-16 セラニーズ・イーブイエイ・パフォーマンス・ポリマーズ・エルエルシー 高分子薬剤化合物の持続放出用の埋め込み型デバイス
CN113365634A (zh) * 2018-12-11 2021-09-07 卢品公司 超低剂量雌激素组合的药物递送系统及其方法和用途
US10632066B1 (en) 2019-02-01 2020-04-28 The Population Council, Inc. Method of providing birth control
US11529308B2 (en) 2019-06-21 2022-12-20 The Population Council, Inc. System for providing birth control
US10918649B2 (en) 2019-06-21 2021-02-16 The Population Council, Inc. System for providing birth control
CN113164383B (zh) 2019-10-12 2022-08-12 国家卫生健康委科学技术研究所 用于黄体支持的阴道缓释给药系统及其制备方法与应用
IL293335A (en) 2019-11-27 2022-07-01 Oak Crest Inst Of Science Sustained release drug delivery device
USD935018S1 (en) 2020-04-07 2021-11-02 The Population Council, Inc. Contraceptive
AU2023205140A1 (en) 2022-01-06 2024-08-01 Oak Crest Institute Of Science Subdermal implant for sustained drug delivery
WO2024115763A1 (en) 2022-12-02 2024-06-06 Vari Bioscience Gmbh Estriol vaginal ring

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3040978A1 (de) * 1980-10-28 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen Vaginalring
ZA857643B (en) * 1984-10-12 1986-05-28 Akzo Nv Release system for two or more active substances
US4816258A (en) * 1987-02-26 1989-03-28 Alza Corporation Transdermal contraceptive formulations
ES2054784T3 (es) * 1987-08-08 1994-08-16 Akzo Nv Un metodo para la fabricacion de un implante.
JPH03123727A (ja) * 1989-10-04 1991-05-27 Nitto Denko Corp 経皮吸収製剤
WO1997002015A1 (en) * 1995-07-04 1997-01-23 Akzo Nobel N.V. Ring-shaped devices
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
TW358031B (en) * 1997-04-11 1999-05-11 Akze Nobel N V Drug delivery system for 2 or more active substances

Also Published As

Publication number Publication date
DE69803112D1 (de) 2002-02-14
US5989581A (en) 1999-11-23
CN1196930A (zh) 1998-10-28
IL123813A0 (en) 1998-10-30
JPH10287549A (ja) 1998-10-27
JP2009256378A (ja) 2009-11-05
PL192449B1 (pl) 2006-10-31
ATE211646T1 (de) 2002-01-15
CZ294099B6 (cs) 2004-10-13
DK0876815T3 (da) 2002-04-22
SG65061A1 (en) 1999-05-25
PT876815E (pt) 2002-07-31
HUP9800863A3 (en) 2000-06-28
AU726934B2 (en) 2000-11-23
DE69803112T2 (de) 2002-07-18
KR19980081290A (ko) 1998-11-25
NO981638D0 (no) 1998-04-08
RU2206325C2 (ru) 2003-06-20
KR100492676B1 (ko) 2005-10-19
TR199800648A1 (xx) 1998-10-21
EP0876815A1 (en) 1998-11-11
EP0876815B1 (en) 2002-01-09
CA2233753C (en) 2001-12-25
BR9801027A (pt) 2000-01-11
TW358031B (en) 1999-05-11
AU6075198A (en) 1998-10-15
ZA982911B (en) 1998-10-09
HU9800863D0 (en) 1998-05-28
ID21259A (id) 1999-05-12
IL123813A (en) 2001-11-25
BR9801027B1 (pt) 2009-01-13
AR011709A1 (es) 2000-08-30
CZ110298A3 (cs) 1998-10-14
NO981638L (no) 1998-10-12
PL325774A1 (en) 1998-10-12
HU222343B1 (hu) 2003-06-28
NZ330145A (en) 1999-05-28
HUP9800863A2 (hu) 1999-02-01
NO320394B1 (no) 2005-11-28
ES2171283T3 (es) 2002-09-01
CN1163222C (zh) 2004-08-25
CA2233753A1 (en) 1998-10-11
JP4982670B2 (ja) 2012-07-25

Similar Documents

Publication Publication Date Title
HK1016886A1 (en) Drug delivery system for two or more active substances
GB2338414B (en) Intravesical drug delivery system
HUP0001914A3 (en) Biocompatible compounds for pharmaceutical drug delivery systems
EP0981333A4 (en) INNOVATIVE SYSTEM FOR THE ADMINISTRATION OF ACTIVE MEDICINES BY AN ACOUSTIC PROCEDURE
AU7493398A (en) Pulsatile drug delivery system
IL125042A (en) Gastrointestinal drug delivery system
AU6140598A (en) Multipathway electronically-controlled drug delivery system
HUP0000299A3 (en) Pharmaceutical formulations for sustained drug delivery
GB9818346D0 (en) Drug dispensing system
EP1061987A4 (en) DEVICE FOR ADMINISTERING A MEDICINAL PRODUCT
EG20670A (en) Active substance delivery system
EP0989878A4 (en) DRUG DELIVERY SYSTEM
ZA97976B (en) Uniform drug delivery theraphy.
AU7201998A (en) Drug delivery system
ZA983169B (en) Pharmaceutical dosage units
EP1021137A4 (en) ARRANGEMENT FOR MEDICINE DELIVERY
IL113793A (en) Transdermal delivery system comprising tiagabine for anti-epileptic drugs
GB9714750D0 (en) Drug delivery device
AU2420997A (en) Oligopeptides for drug delivery
EP0913159A4 (en) DRUG DELIVERY SYSTEM USING GALACTOXYLOGLUCANE
GB9404293D0 (en) Drug delivery system
GB9600471D0 (en) Drug delivery system
GB9700355D0 (en) Drug delivery system
AUPO820797A0 (en) Drug delivery system
GB9800835D0 (en) Drug delivery system

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20180408